Braveheart announces that on 18 November 2020, it sold a total of 112,592,405 ordinary shares in Remote Monitored System plc (“RMS”).
Braveheart announces that on 18 November 2020, it sold a total of 112,592,405 ordinary shares in Remote Monitored System plc (“RMS”).
Braveheart announces that on 16 and 17 November 2020, it sold a total of 287,400,000 ordinary shares in Remote Monitored System plc (“RMS”) at a weighted average price of approximately
Braveheart announces that on 6 November 2020 it exercised a total of 10 million options over ordinary shares in Remote Monitored Systems plc (“RMS”) at an exercise price of 0.5p
Braveheart Investment Group (AIM: BRH) provides an update on progress with the Pharm2Farm Limited (“P2F”) anti-viral surgical mask project.
Braveheart Investment Group (AIM: BRH), is pleased to provide an update concerning progress with proof of concept for a COVID-19 test that Paraytec Limited is conducting with the University of
Braveheart Investment Group (AIM: BRH), is pleased to provide an update concerning progress with proof of concept for a COVID-19 test that Paraytec Limited is conducting with the University of
Conditional Sale of Pharm 2 Farm Limited holding to Remote Monitored Systems plc
Further to the announcement made on 7 July 2020, Braveheart is pleased to provide an update concerning the development of a COVID-19 test that Paraytec Limited is conducting with the
Braveheart is pleased to provide an update concerning the development of a COVID-19 test that Paraytec Limited is conducting with the University of Sheffield.
Braveheart is pleased to provide an update concerning the development of a COVID-19 test with the University of Sheffield.